COMPARE · Reviewed August 3, 2026
HNGE vs HQY
Verdict: Side-by-side breakdown using the Bull Rankings model. HNGE scored 72.0, HQY scored 67.6 — HNGE leads.
Compare another set
HNGE
Hinge Health, Inc.
72
$81.22 · $6.3B
fundamentals as of
Score gap
4.4
HNGE leads
HQY
HealthEquity, Inc.
67.6
$104.45 · $8.7B
fundamentals as of
The model, pillar by pillar (0–100 each)
HNGE
stronger →← stronger
HQY
62
Qualityreturns · margins · balance sheet
70
100
Growthrevenue & earnings expansion
69
60
Valuevaluation vs sector peers
64
HQY is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
HNGE
HQY
$209mC
FCF
$488mC
+49.8%A
Rev
+7.6%B
0.02A-
D/E
0.48B
9.7xC+
P/S
—
—
PEG
1.44B
—
P/E
39.1xC+
Winner per row is the stronger grade in our model; a tie or a missing value shows no highlight.
Valuation · DCF cross-check
HNGE
HQY
28% above
Price vs fair valuelower is cheaper
7% below
~21%/yr
Growth the price implies10-yr FCF · lower = less priced in
~8%/yr
-41%
1-yr DCF upside
-8%
-22%
5-yr DCF upside
+8%
+17%
10-yr DCF upside
+35%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
HNGE
Why this score
- Short track record
HQY
Why this score
- Buying back stock
The companies
HNGEHinge Health, Inc.
Why now
Health Information Services · market cap $6.3b. 11% off the 52-week high of $91.50. Revenue growing +50% — in hypergrowth territory. 15 sell-side analysts rate this a Buy with a mean 1-yr target of $92.67 (implying +14% upside).
Moat
Turnaround / out-of-favor name — GAAP-unprofitable for now, so the durability case is forward-looking: it rests on a recovery (margin normalization, a cyclical upturn or restructuring) or an un-monetized asset (IP / network effects / first-mover position) rather than on current reported results.
Risk
Currently unprofitable (margin -78.9%) — path to GAAP profitability is the core thesis risk. ROE -457% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
HQYHealthEquity, Inc.
Why now
Health Information Services · market cap $8.7b. Trading near 52-week high of $105.96 — momentum setup, limited technical margin of safety. 15 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $118.53 (implying +13% upside).
Moat
Net margin 17% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. ROE 11% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere. Free cash flow runs well ahead of reported net income — non-cash charges (depreciation, intangible amortization) are holding down GAAP earnings while cash generation stays strong.
Risk
Trading within 1% of the 52-week high — limited technical margin of safety; a momentum reversal would test conviction. Trailing P/E 39x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.